Search


Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Pharmaceutical dose form grouper concepts specifying "infusion and/or injection" are modeled using General Concept Inclusions (GCIs).  These grouper concepts are the inferred parent of existing concepts that specify "infusion or injection".   

For example,

...

    • 1208958005 |Conventional release solution for infusion and/or injection (dose form)|
Info

Pharmaceutical dose form concepts specifying "infusion and injection" can be created in a national extension if needed. These concepts would be modeled using multiple

Concept
t736472000 |Has dose form administration method (attribute)|
attributes and would be subtypes of existing concepts that specify "infusion or injection".

    • 1236769008 |Gas for conventional release dispersion for infusion and/or injection (dose form)|
    • 1237269000 |Concentrate for conventional release solution for infusion and/or injection (dose form)|
Info

The following are out of scope for the international release but can be added to national extensions, concepts that specify:

  • "infusion or injection"   
  • "infusion and injection"

Clinical drugs with infusion and/or injection

Clinical drugs modeled using Clinical drug (CD) concepts modeled using the new pharmaceutical dose form groupers for “infusion and/or injection” are included in scope for the International Release.

For example,

    • 1252729004 |Product containing precisely remdesivir 5 ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)

...

    • | is modeled with |Has manufactured dose form (attribute)| of |Conventional release solution for infusion and/or injection (dose form)|.

Image Added

Caption label
CapIdid-1905
CapTypeFigure
Stated view of 1252729004 |Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)|

In cases where corresponding CD concepts clinical drugs for both injection and infusion exist, the grouper for “infusion and/or injection” will should be created.  In other words, when creating a new clinical drug for infusion and an existing injection concept exists with the same substance and strength, then the grouper "for infusion and/or injection" should be created.  

For example,

Image Added